News
ENZN
0.060
NaN%
--
Enzon Extends Exchange Offer For Series C Preferred Stock, Shares Jump 20%
NASDAQ · 1d ago
Enzon Extends Rights Plan and Preferred Stock Exchange
TipRanks · 1d ago
Enzon announces extension of exchange offer
TipRanks · 1d ago
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
Barchart · 2d ago
Enzon Extends Exchange Offer Amid Pending Viskase Merger
TipRanks · 3d ago
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
Barchart · 3d ago
Weekly Report: what happened at ENZN last week (0302-0306)?
Weekly Report · 4d ago
Enzon posts FY 2025 operating loss of USD 5.3 million
Reuters · 03/02 21:57
Weekly Report: what happened at ENZN last week (0223-0227)?
Weekly Report · 03/02 09:09
Enzon Extends Rights Plan and Preferred Exchange Offer
TipRanks · 02/27 14:16
Enzon announces extension of exchange offer
TipRanks · 02/27 13:57
Enzon Pharmaceuticals Extends Series C Preferred Stock Exchange Offer Deadline to March 9, 2026
Reuters · 02/27 13:45
Weekly Report: what happened at ENZN last week (0216-0220)?
Weekly Report · 02/23 09:10
Weekly Report: what happened at ENZN last week (0209-0213)?
Weekly Report · 02/16 09:10
Enzon Shareholders Approve Reverse Split and Viskase Merger
TipRanks · 02/11 22:27
Enzon Pharmaceuticals Inc. held shareholder meeting
Reuters · 02/11 22:15
Weekly Report: what happened at ENZN last week (0202-0206)?
Weekly Report · 02/09 09:10
Weekly Report: what happened at ENZN last week (0126-0130)?
Weekly Report · 02/02 09:10
ENZON ANNOUNCES COMMENCEMENT OF EXCHANGE OFFER RELATING TO SERIES C NON-CONVERTIBLE REDEEMABLE PREFERRED STOCK IN CONNECTION WITH VISKASE MERGER
Reuters · 01/30 22:15
Enzon Pharmaceuticals Extends Section 382 Rights Plan Again
TipRanks · 01/30 13:53
More
Webull provides a variety of real-time ENZN stock news. You can receive the latest news about Enzon Pharma through multiple platforms. This information may help you make smarter investment decisions.
About ENZN
Enzon Pharmaceuticals, Inc. is an acquisition vehicle company. The Company intends to become an acquisition platform. The Company utilizes its net operating loss carryforwards (NOLs) to enhance stockholder value. It is involved in pursuing, sourcing, reviewing, and evaluating various potential acquisition transactions.